Your browser doesn't support javascript.
loading
'ADVANCE' (a pilot trial) ADjuVANt chemotherapy in the elderly: Developing and evaluating lower-toxicity chemotherapy options for older patients with breast cancer.
Freedman, Rachel A; Li, Tianyu; Sedrak, Mina S; Hopkins, Judith O; Tayob, Nabihah; Faggen, Meredith G; Sinclair, Natalie F; Chen, Wendy Y; Parsons, Heather A; Mayer, Erica L; Lange, Paulina B; Basta, Ameer S; Perilla-Glen, Adriana; Lederman, Ruth I; Wong, Andrew; Tiwari, Abhay; McAllister, Sandra S; Mittendorf, Elizabeth A; Miller, Peter G; Gibson, Christopher J; Burstein, Harold J.
Afiliação
  • Freedman RA; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA; Harvard Medical School, Boston, MA, USA. Electronic address: rafreedman@partners.org.
  • Li T; Department of Data Sciences, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Sedrak MS; Department of Medical Oncology and Therapeutics Research, City of Hope, Duarte, CA, USA.
  • Hopkins JO; Novant Health Cancer Institute / SCOR NCORP, Winston Salem, NC, USA.
  • Tayob N; Harvard Medical School, Boston, MA, USA; Department of Data Sciences, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Faggen MG; Dana-Farber Brigham Cancer Center at South Shore Hospital, South Weymouth, MA, USA.
  • Sinclair NF; Dana-Farber Brigham Cancer Center at Milford Regional Medical Center, Milford, MA, USA.
  • Chen WY; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA; Harvard Medical School, Boston, MA, USA.
  • Parsons HA; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA; Harvard Medical School, Boston, MA, USA.
  • Mayer EL; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA; Harvard Medical School, Boston, MA, USA.
  • Lange PB; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Basta AS; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Perilla-Glen A; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Lederman RI; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Wong A; Department of Medical Oncology and Therapeutics Research, City of Hope, Duarte, CA, USA.
  • Tiwari A; Department of Medical Oncology and Therapeutics Research, City of Hope, Duarte, CA, USA.
  • McAllister SS; Harvard Medical School, Boston, MA, USA; Hematology Division, Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA; Harvard Stem Cell Institute, Cambridge, MA, USA; Broad Institute of the Massachusetts Institute of Technology and Harvard University, Cambridge, MA, USA.
  • Mittendorf EA; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA; Harvard Medical School, Boston, MA, USA; Division of Breast Surgery, Department of Surgery, Brigham and Women's Hospital, Boston, MA, USA.
  • Miller PG; Harvard Medical School, Boston, MA, USA; Broad Institute of the Massachusetts Institute of Technology and Harvard University, Cambridge, MA, USA; Center for Cancer Research, Massachusetts General Hospital, Boston, MA, USA.
  • Gibson CJ; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA; Harvard Medical School, Boston, MA, USA.
  • Burstein HJ; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA; Harvard Medical School, Boston, MA, USA.
J Geriatr Oncol ; 14(1): 101377, 2023 Jan.
Article em En | MEDLINE | ID: mdl-36163163

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama Tipo de estudo: Prognostic_studies Limite: Aged / Female / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama Tipo de estudo: Prognostic_studies Limite: Aged / Female / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article